What Are the Classes of Obesity? BMI and Beyond

Obesity is divided into three classes based on body mass index (BMI): Class 1 (BMI 30 to 34.9), Class 2 (BMI 35 to 39.9), and Class 3 (BMI 40 or greater). These categories help gauge the level of health risk associated with excess body fat, with risk increasing at each tier. But BMI classes are only one piece of the picture, and newer systems go further by factoring in how obesity actually affects your body.

The Three BMI-Based Classes

The standard classification system uses BMI, a number calculated from your height and weight. For adults, a BMI of 25 to 29.9 is considered overweight. Once you cross the threshold of 30, the obesity classes begin:

  • Class 1 Obesity: BMI of 30 to 34.9
  • Class 2 Obesity: BMI of 35 to 39.9
  • Class 3 Obesity (Severe Obesity): BMI of 40 or greater

Class 3 is sometimes still called “morbid obesity” in older medical literature, though most guidelines now use “severe obesity” instead. The CDC notes that BMI is a screening measure, not a diagnosis on its own, and should be considered alongside other factors when assessing health.

Why BMI Alone Can Be Misleading

BMI doesn’t distinguish between muscle and fat, and it doesn’t tell you where fat is stored. Someone with a high amount of muscle mass can land in the “obese” BMI range without carrying dangerous levels of body fat. Conversely, a person with a normal BMI can carry excess fat around their organs, a pattern linked to heart disease and diabetes.

Body fat percentage offers a more direct measure. The American Council on Exercise defines obesity as body fat at or above 32% for women and at or above 25% for men. These thresholds exist because the health consequences of excess fat depend on how much fat you actually carry, not just what you weigh relative to your height.

Waist circumference adds another layer of useful information. Research from the National Health and Nutrition Examination Survey found that health risks climb sharply at around 96 cm (about 38 inches) for men and 86 cm (about 34 inches) for women. Fat stored around the midsection is more metabolically active and more strongly tied to conditions like type 2 diabetes and cardiovascular disease than fat stored in the hips or thighs.

Lower Thresholds for Asian Populations

The standard BMI cutoffs were developed primarily from data on European populations, and they don’t apply equally to everyone. People of Asian descent tend to develop obesity-related health problems at lower BMIs. A WHO expert consultation found that the BMI at which risk begins to climb for Asian populations ranges from 22 to 25, compared to 25 for the general cutoff. High-risk levels start between 26 and 31, well below the standard obesity threshold of 30.

Based on these findings, public health action points for Asian populations have been proposed at BMIs of 23, 27.5, 32.5, and 37.5. This means someone of South or East Asian descent with a BMI of 27 may face the same health risks as someone of European descent with a BMI of 30 or higher. If you fall into this category, the standard class system can underestimate your risk.

Clinical Staging Beyond BMI

A growing number of clinicians use staging systems that focus on what obesity is doing to your health rather than just how much you weigh. The Edmonton Obesity Staging System (EOSS) sorts people into five stages:

  • Stage 0: No obesity-related health issues
  • Stage 1: Risk factors present (borderline blood pressure, mildly elevated blood sugar, occasional joint pain)
  • Stage 2: Established conditions like type 2 diabetes, sleep apnea, or moderate limitations in daily activity
  • Stage 3: Significant organ damage or serious chronic disease
  • Stage 4: End-stage, life-threatening conditions

This system matters because two people with identical BMIs can have vastly different health profiles. Someone with a BMI of 36 and no metabolic problems (Stage 0) faces a very different outlook than someone at the same BMI with established heart disease (Stage 3). Treatment decisions increasingly depend on staging rather than BMI class alone.

Preclinical vs. Clinical Obesity

A 2025 scientific statement from the American College of Cardiology introduced a clearer distinction between two broad categories. Preclinical obesity describes a state where someone carries excess body fat but their organs and tissues still function normally. Clinical obesity means that excess fat has begun to alter the function of tissues, organs, or overall health. This framing reinforces the idea that carrying extra weight doesn’t automatically mean you’re sick, but it does mean the risk is elevated and monitoring matters.

Under this framework, excess adiposity isn’t confirmed by BMI alone. It requires either a direct body fat measurement or at least one additional measure like waist circumference, waist-to-hip ratio, or waist-to-height ratio using sex-specific thresholds. This pushes the definition of obesity closer to what’s actually happening in your body rather than relying on a single number from a scale.

How Children Are Classified

For children and teens aged 2 through 19, obesity isn’t defined by fixed BMI numbers. Instead, it’s based on how a child’s BMI compares to others of the same age and sex. A child at or above the 85th percentile but below the 95th percentile is classified as overweight. At the 95th percentile or above, the classification is obesity. These percentile-based cutoffs exist because BMI shifts naturally as children grow, making fixed thresholds unreliable for younger populations.

Which Classification Matters Most

If you’re trying to understand where you stand, the BMI classes are a reasonable starting point, but they’re the beginning of the conversation, not the end. Your waist measurement, body fat distribution, blood sugar, blood pressure, cholesterol levels, and how you feel physically all factor into the real picture. Someone classified as Class 1 by BMI but already dealing with sleep apnea and prediabetes is in a different situation than someone in Class 2 who has no metabolic issues at all. The trend in medicine is moving toward treating obesity as a spectrum of health impact, not just a number on the scale.